ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2023
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » World News

Exclusive: Pfizer to launch consumer health sale in November -sources

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App

Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.

Several global companies, including GlaxoSmithKline and Reckitt Benckiser, have expressed interest in bidding for the unit, which had sales of about $3.4 billion in 2016.

The prospective sale, which is being led by Centerview Partners, Guggenheim Securities and Morgan Stanley, was first mooted on Oct. 10, when Pfizer said it was considering strategic options for the unit.

But preliminary discussions with interested parties including Reckitt have already taken place, one of the sources said, adding the U.S. drugmaker wants to get the ball rolling before the end of this year.

GSK Chief Executive Emma Walmsley confirmed on Wednesday she would look "carefully" at the business.

Three people familiar with the situation said the British drugmaker had hired Citi to represent it in the auction. GSK declined to comment while Citi was not immediately available.

Other possible bidders could include Procter & Gamble, Sanofi, Johnson & Johnson and Nestle, several sources said.

Pfizer plans to send out financial information about the consumer unit to prospective buyers in around three weeks time, one of the sources said.

The process is expected to heat up early next year as bids come in and a deal could be sealed around the middle of 2018, the source said.

Germany`s Merck KGaA is also looking to divest its consumer health business and has hired JP Morgan to sell the unit, best known for making Seven Seas vitamins.

Some banking and industry sources said Merck could put the divestment on hold since the sale, estimated to be worth around $4.5 billion, risked being eclipsed by the Pfizer auction.

One source said Pfizer believed keen competition would allow it to raise at least $20 billion from the sale of the business, whose well-known brands include painkiller Advil, Centrum multivitamins and lip balm Chapstick.

As ageing populations and health-conscious consumers drive demand for self-medication, the consumer health sector has proved a fertile ground for deal-making in recent years.

But the industry remains fragmented and GSK`s Walmsley said she expected more merger activity, with GSK in a strong position to act as a "consolidator".

Although consumer remedies sold over the counter have lower margins than prescription drugs, they are typically very long-lasting brands with loyal customers.

Pfizer Chief Executive Ian Read said he was considering the sale of consumer healthcare because it was not integral to the core prescription drug business and might be worth more outside the group.

GSK has taken a different view, opting to retain a diverse portfolio in which consumer health offers a hedge against riskier prescription drugs.

For Reckitt, meanwhile, over-the-counter medicines offer higher-margin growth than its household business. Chief Executive Rakesh Kapoor, who last week announced plans to separate Reckitt into health and home and hygiene divisions, said he would weigh a bid if Pfizer`s strategic review resulted in a sale.

Nestle could also enter the fight and use the Pfizer consumer business as a platform to expand the intersection of food and healthcare, sources said. The Swiss group has previously identified consumer healthcare as a sector of interest.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Economy
Updated: Thu, Oct 26, 2017
11:07 am
Reuters
RELATED NEWS
RBI to hike repo rate by 25 bps in February, ending tightening cycle: Reuters poll RBI to hike repo rate by 25 bps in February, ending tightening cycle: Reuters poll
Pakistan raises petrol price by Rs 35, pushing retail cost to a whopping Rs 249.80 per litre amid severe food, energy crisis Pakistan raises petrol price by Rs 35, pushing retail cost to a whopping Rs 249.80 per litre amid severe food, energy crisis
Budget 2023: Why budget's printing was shifted to North Block from Rashtrapati Bhavan? Budget 2023: Why budget's printing was shifted to North Block from Rashtrapati Bhavan?
Govt to sell 30 lakh tonnes of wheat in open market till March to control prices of wheat, atta Govt to sell 30 lakh tonnes of wheat in open market till March to control prices of wheat, atta
India’s economic fortunes critical for global growth, its rise being welcomed by world: Kumar Mangalam Birla India’s economic fortunes critical for global growth, its rise being welcomed by world: Kumar Mangalam Birla

LATEST NEWS

Brokerage Views: Tech Mahindra, Larsen & Toubro, PNB, BPCL, GAIL in focus today

362 trains cancelled by Indian Railways today, January 31 - Check full list; IRCTC refund rule and ticket cancellation charges

Timing of Hindenburg Research report suspicious: MK Ventures' founder Madhu Kela

Sanjiv Bhasin strategy stocks today Buy Tata Power and Bank of Baroda shares check price targets

Toyota Urban Cruiser Hyryder CNG variant launched in India: Check price, variants, features, other details here

Closing Bell: Sensex, Nifty rebound from 3-month lows, break 2-day losing streak; Bajaj twins among top gainers

Dalal Street fixes its gaze on Budget 2023, FOMC meeting; 10 triggers that could impact Sensex, Nifty on Tuesday

What happens to your mutual fund investment if you miss SIP?

What is Follow on Public Offer and how it is different from IPO? Explained

Snowfall in Udaipur: Temperature dips as rain lashes parts of Rajasthan; check weather forecast

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. India Dot Com Private Limited. All Rights Reserved.
LIVE TV